417 related articles for article (PubMed ID: 34570177)
1. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial.
Vossel K; Ranasinghe KG; Beagle AJ; La A; Ah Pook K; Castro M; Mizuiri D; Honma SM; Venkateswaran N; Koestler M; Zhang W; Mucke L; Howell MJ; Possin KL; Kramer JH; Boxer AL; Miller BL; Nagarajan SS; Kirsch HE
JAMA Neurol; 2021 Nov; 78(11):1345-1354. PubMed ID: 34570177
[TBL] [Abstract][Full Text] [Related]
2. Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial.
Koch G; Motta C; Bonnì S; Pellicciari MC; Picazio S; Casula EP; Maiella M; Di Lorenzo F; Ponzo V; Ferrari C; Scaricamazza E; Caltagirone C; Martorana A
JAMA Netw Open; 2020 Jul; 3(7):e2010372. PubMed ID: 32667654
[TBL] [Abstract][Full Text] [Related]
3. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS
JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367
[TBL] [Abstract][Full Text] [Related]
4. Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.
Tsai RM; Miller Z; Koestler M; Rojas JC; Ljubenkov PA; Rosen HJ; Rabinovici GD; Fagan AM; Cobigo Y; Brown JA; Jung JI; Hare E; Geldmacher DS; Natelson-Love M; McKinley EC; Luong PN; Chuu EL; Powers R; Mumford P; Wolf A; Wang P; Shamloo M; Miller BL; Roberson ED; Boxer AL
JAMA Neurol; 2020 Feb; 77(2):215-224. PubMed ID: 31710340
[TBL] [Abstract][Full Text] [Related]
5. Treatment of epilepsy for people with Alzheimer's disease.
Liu J; Wang LN
Cochrane Database Syst Rev; 2021 May; 5(5):CD011922. PubMed ID: 33973646
[TBL] [Abstract][Full Text] [Related]
6. Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial.
Lin CH; Chen PK; Wang SH; Lane HY
JAMA Netw Open; 2021 Apr; 4(4):e216156. PubMed ID: 33881530
[TBL] [Abstract][Full Text] [Related]
7. Treatment of epilepsy for people with Alzheimer's disease.
Liu J; Wang LN; Wu LY; Wang YP
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011922. PubMed ID: 30570742
[TBL] [Abstract][Full Text] [Related]
8. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
Porsteinsson AP; Drye LT; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG;
JAMA; 2014 Feb; 311(7):682-91. PubMed ID: 24549548
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults.
Schoenberg MR; Rum RS; Osborn KE; Werz MA
Epilepsia; 2017 Sep; 58(9):1566-1574. PubMed ID: 28731266
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
Wessels AM; Tariot PN; Zimmer JA; Selzler KJ; Bragg SM; Andersen SW; Landry J; Krull JH; Downing AM; Willis BA; Shcherbinin S; Mullen J; Barker P; Schumi J; Shering C; Matthews BR; Stern RA; Vellas B; Cohen S; MacSweeney E; Boada M; Sims JR
JAMA Neurol; 2020 Feb; 77(2):199-209. PubMed ID: 31764959
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.
Quinn JF; Raman R; Thomas RG; Yurko-Mauro K; Nelson EB; Van Dyck C; Galvin JE; Emond J; Jack CR; Weiner M; Shinto L; Aisen PS
JAMA; 2010 Nov; 304(17):1903-11. PubMed ID: 21045096
[TBL] [Abstract][Full Text] [Related]
12. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
[TBL] [Abstract][Full Text] [Related]
13. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
De Jesus Moreno Moreno M
Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
[TBL] [Abstract][Full Text] [Related]
14. An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
Sen A; Akinola M; Tai XY; Symmonds M; Davis Jones G; Mura S; Galloway J; Hallam A; Chan JYC; Koychev I; Butler C; Geddes J; Van Der Putt R; Thompson S; Manohar SG; Frangou E; Love S; McShane R; Husain M
Trials; 2021 Jul; 22(1):508. PubMed ID: 34332638
[TBL] [Abstract][Full Text] [Related]
15. Seizures and epileptiform activity in the early stages of Alzheimer disease.
Vossel KA; Beagle AJ; Rabinovici GD; Shu H; Lee SE; Naasan G; Hegde M; Cornes SB; Henry ML; Nelson AB; Seeley WW; Geschwind MD; Gorno-Tempini ML; Shih T; Kirsch HE; Garcia PA; Miller BL; Mucke L
JAMA Neurol; 2013 Sep; 70(9):1158-66. PubMed ID: 23835471
[TBL] [Abstract][Full Text] [Related]
16. Metal protein attenuating compounds for the treatment of Alzheimer's dementia.
Sampson EL; Jenagaratnam L; McShane R
Cochrane Database Syst Rev; 2012 May; 5(5):CD005380. PubMed ID: 22592705
[TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
Baker LD; Barsness SM; Borson S; Merriam GR; Friedman SD; Craft S; Vitiello MV
Arch Neurol; 2012 Nov; 69(11):1420-9. PubMed ID: 22869065
[TBL] [Abstract][Full Text] [Related]
18. Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.
Vossel KA; Ranasinghe KG; Beagle AJ; Mizuiri D; Honma SM; Dowling AF; Darwish SM; Van Berlo V; Barnes DE; Mantle M; Karydas AM; Coppola G; Roberson ED; Miller BL; Garcia PA; Kirsch HE; Mucke L; Nagarajan SS
Ann Neurol; 2016 Dec; 80(6):858-870. PubMed ID: 27696483
[TBL] [Abstract][Full Text] [Related]
19. Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Howard R; Zubko O; Bradley R; Harper E; Pank L; O'Brien J; Fox C; Tabet N; Livingston G; Bentham P; McShane R; Burns A; Ritchie C; Reeves S; Lovestone S; Ballard C; Noble W; Nilforooshan R; Wilcock G; Gray R;
JAMA Neurol; 2020 Feb; 77(2):164-174. PubMed ID: 31738372
[TBL] [Abstract][Full Text] [Related]
20. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
